CBR-3465

• UNSPSC Description:

  CBR-3465 is a mycobacterium tuberculosis (Mtb) type II NADH dehydrogenase inhibitor, with the MIC of 0.16 μM against Mtb[1].

• Target Antigen:

  Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/cbr-3465.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1N=C(NC2=C1C(F)=CC=C2)SCC(NC3CCCCC3)=O

• Molecular Weight:

  335.40

• References & Citations:

  [1]Harbut MB, et, al. Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity. Angew Chem Int Ed Engl. 2018 Mar 19;57(13):3478-3482.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2225883-59-8